Education
About Us
Working with TipRanks
Follow Us
scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
SCPH Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SCPH Stock 12 Month Forecast
Average Price Target
$15.60
▲(305.19%Upside)
| Highest Price Target$25.00 | Average Price Target$15.60 | Lowest Price Target$11.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$4
Hold
3.90%
Upside
Reiterated
06/05/25
scPharmaceuticals' stock score is primarily influenced by its challenging financial position, with high debt levels and negative cash flows. While technical indicators suggest strong momentum, the potential near-term pullback due to overbought conditions and the negative valuation metrics indicate caution. The earnings call provided positive insights, but its impact is not included in the weighted score.
Maxim Group
$12
Buy
211.69%
Upside
Reiterated
05/20/25
H.C. Wainwright
$18
Buy
367.53%
Upside
Reiterated
05/15/25
Craig-Hallum
$12
Buy
211.69%
Upside
Reiterated
05/15/25
Leerink Partners
$11
Buy
185.71%
Upside
Reiterated
05/15/25
TD Cowen
$25
Buy
549.35%
Upside
Reiterated
05/14/25
Jefferies
$16→$13
Buy
237.66%
Upside
Reiterated
12/02/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$4
Hold
3.90%
Upside
Reiterated
06/05/25
scPharmaceuticals' stock score is primarily influenced by its challenging financial position, with high debt levels and negative cash flows. While technical indicators suggest strong momentum, the potential near-term pullback due to overbought conditions and the negative valuation metrics indicate caution. The earnings call provided positive insights, but its impact is not included in the weighted score.
Maxim Group
$12
Buy
211.69%
Upside
Reiterated
05/20/25
H.C. Wainwright
$18
Buy
367.53%
Upside
Reiterated
05/15/25
Craig-Hallum
$12
Buy
211.69%
Upside
Reiterated
05/15/25
Leerink Partners
$11
Buy
185.71%
Upside
Reiterated
05/15/25
TD Cowen
$25
Buy
549.35%
Upside
Reiterated
05/14/25
Jefferies
$16→$13
Buy
237.66%
Upside
Reiterated
12/02/24
Best Analysts Covering scPharmaceuticals
1 Month
xxx
Success Rate
9/19 ratings generated profit
Average Return
+1.79%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.37% of your transactions generating a profit, with an average return of +1.79% per trade.
3 Months
xxx
Success Rate
11/19 ratings generated profit
Average Return
+2.72%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.89% of your transactions generating a profit, with an average return of +2.72% per trade.
1 Year
Success Rate
8/19 ratings generated profit
Average Return
-0.62%
reiterated a buy rating 23 days ago
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -0.62% per trade.
2 Years
xxx
Success Rate
5/15 ratings generated profit
Average Return
-6.33%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -6.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SCPH Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
10
9
11
10
13
Buy
2
2
6
5
5
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
11
17
15
18
Each month's total comprises the sum of three months' worth of ratings.
SCPH Financial Forecast
SCPH Stock Forecast FAQ
What is SCPH’s average 12-month price target, according to analysts?
Based on analyst ratings, scPharmaceuticals Inc’s 12-month average price target is 15.60.
What is SCPH’s upside potential, based on the analysts’ average price target?
scPharmaceuticals Inc has 305.19% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SCPH a Buy, Sell or Hold?
scPharmaceuticals Inc has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is scPharmaceuticals Inc’s price target?
The average price target for scPharmaceuticals Inc is 15.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $11.00. The average price target represents 305.19% Increase from the current price of $3.85.
The highest analyst price target is $25.00 ,the lowest forecast is $11.00. The average price target represents 305.19% Increase from the current price of $3.85.
What do analysts say about scPharmaceuticals Inc?
scPharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of SCPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.